i-SENS Inc. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
82,863
95,608
101,921
132,468
156,964
Cost of Goods Sold (COGS) incl. D&A
48,752
56,712
58,116
72,556
90,433
Gross Income
34,110
38,896
43,804
59,912
66,531
SG&A Expense
15,334
20,413
23,946
33,749
42,776
EBIT
18,557
18,124
19,412
-
22,756
Unusual Expense
1,654
850
372
1,328
614
Non Operating Income/Expense
1,827
524
1,470
511
672
Interest Expense
254
711
744
795
1,239
Pretax Income
22,217
17,340
20,174
22,655
19,475
Income Tax
3,801
2,686
4,482
5,110
4,331
Equity in Affiliates
226
314
1,236
-
-
Consolidated Net Income
18,642
14,340
14,455
17,545
15,144
Net Income
18,642
14,466
14,716
17,561
15,730
Net Income After Extraordinaries
18,642
14,466
14,716
17,561
15,730
Net Income Available to Common
18,642
14,466
14,716
17,561
15,730
EPS (Basic)
1,390.67
1,063.33
1,077.00
1,280.00
1,146.00
Basic Shares Outstanding
13
14
14
14
14
EPS (Diluted)
1,377.89
1,055.26
1,073.42
1,276.53
1,143.34
Diluted Shares Outstanding
14
14
14
14
14
EBITDA
24,846
25,043
26,997
31,410
30,009
Other Operating Expense
219
360
446
583
999
Non-Operating Interest Income
433
253
407
289
167
Minority Interest Expense
-
126
261
16
586
Equity in Affiliates (Pretax)
-
-
-
1,602
2,151

About i-SENS

View Profile
Address
I Sens Building
Seoul SL 06646
Korea, Republic Of
Employees -
Website http://www.i-sens.co.kr
Updated 09/14/2018
i-SENS, Inc. engages in development and manufacture of medical, environmental, industrial sensors. Its products include bolld glucose monitoring devices, electrolyte analyzers and cartridges, blood coagulation measuring instrument, connectors, and others. The company was founded by Cha Geun-Sig and Nam Hak-Hyun on May 4, 2000 and is headquartered in Seoul, South Korea.